Understanding the molecular mechanisms responsible for antimony drug resistance in Leishmania parasites

FHS
June 22, 2023
7:18 pm

Leishmaniasis is a tropical disease caused by parasites known as Leishmania, which are transmitted to humans and animals through the bites of more than 90 species of sand flies.

Manufacturing roundup: EuroAPI to acquire oligonucleotide maker for $10M+; EU nations face Trulicity shortage

EuroAPI will acquire German-based BianoGMP, a contract manufacturer of oligonucleotides, for €10 million, or $10.9 million. Founded in 2017, BianoGMP mainly focuses on producing oligonucleotides

September 1, 2023

Corrected: AstraZeneca, Daiichi Sankyo’s TROP2 ADC boosts survival in Phase 3 lung cancer subgroup

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 29, 2024

Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle science

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.